Nuclear Cardiology | Cardiac Imaging Conferences | Echocardiography Meetings | USA | 2017| Europe |Asia | Middle East

Cardiac Imaging Conferences, Nuclear Cardiology Conferences, Echocardiography Meetings, Cardiac Imaging Conferences USA (America), Nuclear Cardiology Conferences Europe, Cardiac Imaging Conferences Asia, Nuclear Cardiology Conferences Middle East

Previous Speakers

Irena Levitan

University of Illinois USA

Jeffrey R Bender

Yale University School of Medicine USA

Raimund Erbel

University Duisburg-Essen Germany

Branko Furst

Albany Medical College USA

Jens Frahm

Max-Planck-Institut fÃ¼r biophysikalische Chemie Germany

John P Breinholt

University of Texas McGovern Medical School USA

Guy Hugues Fontaine

Universite Pierre et Marie Curie France

Brojendra Agarwala

University of Chicago Medicine Comer Childrenâ€™s Hospital USA

Recommended Global Cardiology Webinars & Conferences

Europe & UK

GERIATRIC CARDIOLOGY 2025, France Hypertension Congress-2025, France Interventional Cardiology 2025, UK Euro Cardiology Congress 2025, Italy Congestive Heart Failure-2025, Switzerland

Asia Pacific & Middle East

Canada

Clinical Cardiology 2025, Canada Heart Congress-2025, Canada Annual Cardiology 2025, Canada

Nuclear Cardiology 2017

About Conference

Conference Series is inviting all participants across the globe to attend 2^nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography during September 11-13, 2017 Amsterdam, Netherlands which is a CME accredited event. This event will bring together world-class professors, scientists and cardiologists to discuss Cardiac imaging, Coronary artery diseses, Cardiac biomarkers, Echocardiogram/Echocardiography, Transesophageal echocardiography, Stress echocardiography, Three-dimensional echocardiography, Pediatric echocardiography, Nuclear Cardiology, Cardiomyopathy and Myocardium. Nuclear Cardiology CME event is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized around the theme "Emerging and Innovative technologies in the fields of Cardiac Imaging, Nuclear Cardiology & Echocardiography”.

This CME accredited conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of nuclear cardiology & echocardiography treatment. This conference mainly focuses on spreading the awareness about challenges in this fields and how to prevent and manage the techniques of Cardiac Imaging, Nuclear Cardiology & Echocardiography.

Conference Series Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma, cardiology diagnosis workshops, cardiac nursing conferences, cardiac conferences and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

CME Credits:

In support of improving patient care, this activity has been planned and implemented by Conference Series, Ltd and Center for Education Development (CED). CED is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Center for Education Development designates the live format for this educational activity for AMA PRA Category 1 Credits™ and ANCC credit. Participants should only claim credit commensurate with the extent of their participation in the activity. Full accreditation information including disclosures, credit hours available and faculty information will be provided in the attendee handout onsite.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about Nuclear Cardiology techiques. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of nuclear cardiology & echocardiography technique and receive name recognition at this 2-days CME event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Nuclear Cardiology are the principal features of this CME accredited conference.

Target Audience:

Our Organization would be privileged to welcome the:

Directors of Nuclear Cardiology & Echocardiography or related Programs or Associations
Heads, Deans and Professors of Nuclear Cardiology & Echocardiography or Cardiology and related departments
Scientists and Researchers
Doctors
Writers
Founders and Employees of the related companies
Nuclear Cardiology & EchocardiographyAssociations and Organizations
Laboratory members and Students working in the field of Nuclear Cardiology

Sessions/Tracks

Conference Series Ltd welcome all the participants from all over the world to attend the 2^nd International Conference on Non-invasive Cardiac Imaging, Nuclear Cardiology & Echocardiography during September 11-13, 2017 at Amsterdam, Netherlands which is a CME accredited conference which incorporates brief keynote presentations, Oral talks, Poster presentations, Exhibitions, Workshops.Nuclear Cardiology CME event is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized around the theme "Emerging and Innovative technologies in the fields of Cardiac Imaging, Nuclear Cardiology & Echocardiography”.

Scientific Sessions:

Track: 1 Cardiac Imaging

Cardiac imaging is visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including Endoscopy, Radionuclide imaging, Magnetic Resonance imaging, Tomography or Ultrasonography. Non-invasive cardiac imaging refers to a combination of methods that can be used to obtain images related to the structure and function of the heart. For invasive technique catheters are used to insert into the heart and this test is easy to perform and safe to detect various heart conditions .As a result of technological advances the number of available non-invasive cardiac tests that physicians can order has increased substantially over the last decade.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Related Conferences: 2^nd international Conference on Hypertension & Healthcare September 11-13, 2017 Amsterdam, Netherlands; 20^th European Cardiology conference October 16-18, 2017 Budapest, Hungary; 21^st International Conference on Clinical & Experimental Cardiology November 06-07, 2017 Las Vegas, USA; Advances in Nuclear Cardiology and Cardiac CT: Annual Case Review With the Experts January 20-22, 2017 Cedars-Sinai, Harvey Morse Conference Center, Los Angeles, California; CVI’s 9th Annual Echocardiography Update: Echocardiography in Heart Failure and Cardio Oncology January 15, 2017 Philadelphia, PA; ICNC 2017, Nuclear Cardiology & Cardiac CT May 07-09, 2017 Vienna, Austria; American Society of Nuclear Cardiology (ASNC) Annual Meeting September 14-17, 2017 Kansas City, Missouri; 24^thEchocardiographic Workshop on 2-D and Doppler Echocardiography at Vail March 6-9, 2017 Vail Marriott, Vail, CO; American Cardiology Association 2017.

Track: 2 Coronary Artery Disease

A coronary artery disease is also known as ischemic heart diseases which is a group of diseases that includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases and most common type. CAD happens when the arteries that supply blood to heart muscle become hardened and narrowed this is due to the build-up of cholesterol and other materials called plaque on their inner walls this build up is called as atherosclerosis as it grows less blood flows through the arteries. As a result the heart muscle can't get the blood or oxygen it needs so this can leads to chest pain (angina) or a heart attack.

Cardiology Conferences | Cardiology Meetings | CME Accredited Event | Nuclear Cardiology Conference

Track: 3 Cardiac Valvular Diseases

Cardiac valvular diseases are also known as Valvular heart diseases is characterized by damage to or a defect in one of four heart valves: the mitral, aortic, tricuspid or pulmonary. These conditions occurs largely as a result of aging and sometimes they don't work properly If they don't, you could have Regurgitation - when blood leaks back through the valve in the wrong direction, Mitral valve prolapse - when one of the valves, the mitral valve, has "floppy" flaps and doesn't close tightly. It's one of the most common heart valve conditions sometimes it causes regurgitation and Stenosis - when the valve doesn't open enough and blocks blood flow.

Valve problems can be present at birth or caused by infections and heart attacks or heart disease. The main sign of heart valve disease is an unusual heartbeat sound called a heart murmur. Heart tests can show if you have a heart valve disease some valve problems are minor and do not need any treatment. Others might require medicine, medical procedures or surgery to repair or replace the valve.

Cardiology Conferences | Cardiology Meetings | CME Accredited Event | Nuclear Cardiology Conference

Track: 4 Cardiac Biomarkers

Cardiac markers are biomarkers which are used to measure the evaluate heart function. These are often discussed in the context of myocardial infarction but other some conditions can lead to elevation in cardiac marker level. Most of the early markers are identified as enzymes so as a result the term Cardiac Enzymes are also used sometimes. Measuring cardiac biomarkers can be a step towards making a diagnosis for a condition whereas cardiac imaging often confirms a diagnosis, simpler and less expensive cardiac biomarker measurements can be done when a physician advise whether more complicated or invasive procedures are warranted. In many cases doctors advertise biomarker measurements an initial testing strategy for patients especially with low risk of cardiac death.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Track: 5 Echocardiogram/Echocardiography

An echocardiogram is called an echo is a type of ultrasound test that uses high pitched sound waves that are sent through a device called transducers. This device picks up echoes of the sound waves as they bound off the different parts of your heart and these echoes are turned into moving pictures of your heart that can been seen on a video screen. Echocardiography uses usual two-dimensional, three-dimensional, and Doppler ultrasound to create images of the heart. Echocardiography has become routinely used in the diagnosis, management, and follow-up of patients with any suspected or known heart diseases. It is one of the most generally used diagnostic tests in cardiology and it can provide wealth information regarding size and shape of heart. Echocardiography is performed by cardiac sonographers, cardiac physiologists, or physicians trained in echocardiography.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Track 6: Three-dimensional Echocardiography

3D echocardiography (also known as 4D echocardiography when the picture is moving) is now possible, using a matrix array ultrasound probe and an appropriate processing system. This enables detailed anatomical assessment of cardiac pathology, particularly valvular defects, and cardiomyopathies. The ability to slice the virtual heart in infinite planes in an anatomically appropriate manner and to reconstruct three-dimensional images of anatomic structures make 3D echocardiography unique for the understanding of the congenitally malformed heart. Real Time 3-Dimensional echocardiography can be used to guide the location of bioptomes during right ventricular endomyocardial biopsies, placement of catheter delivered valvular devices, and in many other intraoperative assessments. The 3D Echo Box developed by the European Association of Echocardiography offers a complete review of three dimensional echocardiography.

CME Accredited Event | Cardiology Conferences | Cardiology Meetings | | Nuclear Cardiology Conference

Track 7: Stress Echocardiography

Stress echocardiography is a test that uses ultrasound imaging to show how well your heart muscle is working to pump blood to your body. A stress echocardiography is also called as echocardiography stress test or stress echo. This test most often uses to detect a decrease in blood flow to the heart from narrowing in the coronary arteries.

This test is done in medical care centres and health care centres. First a resting echocardiogram will be done while you lie on the left side with your left arm out, a small device called a transducer is held against your chest. A special gel is used to detect the ultrasound waves get to your heart. Most of the echocardiogram images will be taken when your heart rate is rising, or when it reaches its peak. The images will show whether any parts of the heart muscle do not work as well when your heart rate raises. This is a sign that part of the heart may not be getting enough blood or oxygen because of narrowed or blocked arteries.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Track 8: Transesophageal Echocardiography

Transesophageal echocardiography is a produces in which whole pictures of your heart can be seen. It uses high-frequency sound waves i.e. ultrasound to make detailed pictures of your heart and the arteries that lead to and from it. Unlike a standard echocardiogram, or the echo transducer that produces the sound waves for TEE is attached to a thin tube that passes through your mouth, down to your throat and finally into your esophagus. Because the esophagus is close to the upper chambers of the heart, so that very clear images of those heart structures and valves can be obtained.

CME Accredited Event | Cardiology Conferences | Cardiology Meetings | | Nuclear Cardiology Conference

Track 9: Pediatric Echocardiography

Pediatric echocardiography is the commonly used test in children to diagnose or rule out heart disease and also to follow children who have already been diagnosed with a heart problem. This test can be performed on children of all ages and sizes including fetuses and newborns. This ultrasound test is done with your child lying down comfortably on a bed or examination table if infants they may be able to lie in their parent’s lap.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Track 10: Cardiovascular Technologists

Cardiovascular technologists and technicians assist physicians in diagnosing and treating cardiac (heart) and peripheral vascular (blood vessel) ailments. Cardiovascular technicians who specialize in electrocardiograms (EKGs), stress testing and Holter monitors are known as cardiographic or EKG technicians. Technologists who use ultrasound to examine the heart chambers, valves, and vessels are referred to as cardiac sonographers. They use ultrasound instrumentation to create images called echocardiograms. Cardiovascular technologists and technicians and vascular technologists use imaging technology to help physicians diagnose cardiac (heart) and peripheral vascular (blood vessel) ailments in patients. Certification is not required to enter the occupation in the United States.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Track 11: Nuclear Cardiology

Nuclear cardiology studies use non-invasive techniques to assess myocardial blood flow check out the pumping function of the heart as well as visualize the size and location of a heart among the techniques of nuclear cardiology, myocardial perfusion imaging is the most generally used. Myocardial perfusion images are connected with exercise to assess the blood flow to the heart muscle and examination can be in the form of walking on the treadmill or riding a stationary bicycle. A chemical stress test using the drug dipyridamole, adenosine, regadenoson, or dobutamine can be function in patients who are not able to exercise maximally, providing similar information about the heart’s blood flow.

CME Accredited Event | Cardiology Conferences | Cardiology Meetings | | Nuclear Cardiology Conference

Track 12: Cardiomyopathy

Cardiomyopathy is a group of diseases that affect the heart muscle. Earlier there are only few or no symptoms, others may have shortness of breath, feel tired, or have swelling of the legs due to heart failure. An irregular heartbeat may occur as well as fainting and increased risk of sudden cardiac death also occurs. Types of cardiomyopathies are hypertrophic cardiomyopathy, dilated cardiomyopathy and restrictive cardiomyopathy. In hypertrophic cardiomyopathy the heart muscles enlarges and become thicknes. In dilated cardiomyopathy the ventricles enlarge and weaken and in restrictive cardiomyopathy the ventricle becomes stiffens.

CME Accredited Event | Cardiology Conferences | Cardiology Meetings | | Nuclear Cardiology Conference

Track 13: Myocardium

The myocardium is the thick, central layer of the heart and is poised of cardiac muscle. Cardiac muscle is very unique because it possesses the characteristics of skeletal muscle and smooth muscle in which skeletal muscle controls the voluntary movement of the body and smooth muscle responsible for the movement of all other body organs. The myocardium is composed of thousands of muscle fibers that are striated and are arranged at irregular intervals throughout the muscle. They connect to each other at points called intercalated discs. These are tiny membranes that divide the ends of the muscle cells, these fibers actually use calcium to cause an electrical conduction to occur. The contraction (heart beat) of the myocardium is responsible for pumping blood with oxygen to the body and body requires oxygen for proper function. Like all body tissues, the myocardium itself requires a blood supply in order to function.

Cardiology Conferences | Cardiology Meetings | CME Event | Nuclear Cardiology Conference

Market Analysis

Marker Analysis Report of Nuclear Cardiology:

Nuclear cardiology studies use non-invasive techniques to estimate myocardial blood flow check out the pumping function of the heart as well as visualize the size and location of a heart among the procedure of nuclear cardiology, myocardial perfusion imaging is the most generally used. Myocardial perfusion images are connected with exercise to assess the blood flow to the heart muscle and diagnosis can be in the form of walking on the treadmill or riding a stationary bicycle. A chemical stress test using the drug dipyridamole, adenosine, regadenoson, or dobutamine can be action in patients who are not able to exercise maximally, providing similar information about the heart’s blood flow. Some of the topics covered by Nuclear Cardiology are Nuclear Medicine Imaging, Myocardial Perfusion Imaging/Nuclear stress Test, Angiocardiography, Cardiac Inflammation, Radiocardiography. Nuclear imaging in cardiac disorders disesase in accurate diagnosis of cardiovascular diseases and blockages in blood flow and is a technique for producing images of various body parts utilizing radioactive materials. The nuclear cardiology market is attract mainly on three major segments namely radiology devices, picture archiving and communications systems, radiology information systems and radiopharmaceuticals.

Importance & Scope:

Nuclear Cardiology (market size worth approximately $25 million) is the most common cardiac imaging technique performed in India today. It accounts for over 60 percent of all cardiac imaging tests. Echocardiography is widely used an important tool primarily in the diagnosis and assessment of valvular heart disease and CAD, hypertrophic cardiomyopathy, aortic dissection, evaluation of complex valve replacements, surgical repair of congenital abnormalities. Based on the type, the nuclear cardiology market is categorized into diagnostic and therapeutic radioisotopes. In 2016, the diagnostic segment accounted for a major share of the nuclear cardiology/radiopharmaceuticals market. On the basis of diagnostic radiopharmaceuticals, the nuclear cardiology/radiopharmaceuticals market is further segmented into SPECT and PET radioisotopes. In 2016, the cardiology application segment accounted for the largest share of the nuclear medicine SPECT applications market.

Market Value of Nuclear Cardiology:

The market report of Nuclear Cardiology for the forecast period of 2016 to 2021 is expected to reach USD 7.27 Billion by 2021 from USD 4.67 Billion in 2016, growing at a CAGR of 9.3%.Based on the type the nuclear cardiology market is divided into diagnostic and therapeutic radioisotopes. In 2016 the diagnostic segment assumed the major share of nuclear cardiology market. Based on the region the market value of Nuclear Cardiology is divided into North-America, Europe, and Asia-pacific. In 2016, North-America assumed for the largest share of market followed by Asia-Pacific and Europe.

Market Growth of Nuclear Cardiology:

The major drives for market growth of Nuclear Cardiology is increasing the use of SPECT and PET scans, advances in radiotracers and alpha radio immunotherapy-based targeted treatment and cardiac ailments. However, some of the factors hindering the growth of the market are radiopharmaceuticals, conventional diagnostic procedures and stringent regulatory guidelines. Some of the major participants in the global market value of Nuclear Cardiology are Cardinal Health Inc. GE Healthcare, Lantheus Medical Imaging, Bayer AG, and IBA Molecular Imaging. These companies are the dominant in the nuclear cardiology market mainly due to well established presence in the field of radiopharmaceuticals, high R&D investments, and strong sales and distribution force.

Past Conference Report

Echocardiography 2016

In the presence of inter professional researchers and practitioners involved in the development of high quality education in all aspects of clinical skills, Conference Series LLC 8^thGlobal Cardiologists and Echocardiography Annual Meeting was held during July 18-20, 2016 in Berlin, Germany.

Conference Series LLC Group played host to a diverse panel of key members of the Cardiologists & Echocardiography community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology specialties. This event was really aimed for examining where the real cardiological specialties are going in the future and purpose of the event was to provide an opportunity for cross fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiologists, Pediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes and the Heart and Heart Failure as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiologists & Echocardiography-2016 Organizing Committee would like to thank the Moderators of the conference, Dr. Irena Levitan, University of Illinois, USA and Dr. Aris Lacis, University Children Hospital, Latvia who contributed a lot for the smooth functioning of this event.

The highlights of the meeting were the eponymous lectures, delivered by Ada Yonath Nobel Laureate 2009 from Weizmann Institute of Science, Isarel, Raimund Erbel from University Duisburg-Essen, Germany, Jens Frahm from Max-Planck-Institut für Biophysikalische Chemie ,Germany, Guy Hugues Fontaine from Universite Pierre et Marie Curie, France, Roland Hetzer from Former Medical Director, German Heart Institute, Germany. These talks were of great interest to the general cardiologists and were enormously informative.

Conference series LLC 8th Global Cardiologists and Echocardiography Annual Meeting was a great success with the support of international, multiprofessional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access. We are happy to announce our 2^nd International Conference on Echocardiography, which will be held during September 11-13, 2017 in Amsterdam, Netherlands.

Past Reports Gallery